2025
SJR Q1
JCR Q1 · 6,2
27 eşleşen makale
SCIE
Dergi ayrıntısı
Inflammation Research
- Yayıncı
- Springer Science and Business Media Deutschland GmbH
- Ülke
- Switzerland · Western Europe
- Tür
- journal
- ISSN
-
102338301420908X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,552
- Quartile Q1
- H-Index 117
- Atıf/yayın 6,19
- Doküman (3y) 429
- Atıf (3y) 2.765
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 6,2
- 5Y JIF 6,2
- JCI 0,86
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Immunology Q1
- Pharmacology Q1
Alanlar
- Immunology and Microbiology
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Cell Biology | Immunology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,552 | 6,2 | 6,2 | 0,86 | Q2 | 117 |
| 2024 | Q1 | Q1 | 1,388 | 5,4 | 5,7 | 0,79 | Q2 | 112 |
| 2023 | Q1 | Q2 | 1,309 | 4,8 | 5,2 | 0,79 | Q2 | 112 |
| 2022 | Q1 | Q2 | 1,339 | 6,7 | 5,8 | 0,78 | Q2 | 112 |
| 2021 | Q1 | Q2 | 1,332 | 7 | 5,6 | 0,77 | Q2 | 112 |
| 2020 | Q1 | Q2 | 1,121 | 4,6 | 4,2 | 0,66 | Q3 | 112 |
| 2019 | Q1 | Q3 | 0,98 | 3,2 | 3,1 | 0,6 | Q3 | 112 |
| 2018 | — | Q3 | — | 3,1 | 3 | 0,61 | Q3 | — |
| 2017 | Q2 | Q3 | 1,062 | 3 | 2,7 | 0,61 | Q3 | 112 |
| 2016 | Q2 | Q3 | 1,025 | 2,7 | 2,4 | — | — | 112 |
| 2015 | Q2 | Q3 | 0,952 | 2,6 | 2,2 | — | — | 112 |
| 2014 | Q2 | Q3 | 0,935 | 2,3 | 2,3 | — | — | 112 |
| 2013 | Q2 | Q3 | 0,839 | 2,1 | 2,1 | — | — | 112 |
| 2012 | Q2 | Q3 | 0,806 | 2 | 2 | — | — | 112 |
| 2011 | Q2 | Q3 | 0,661 | 2,1 | 1,9 | — | — | 112 |
| 2010 | Q2 | Q3 | 0,664 | 2 | 1,8 | — | — | 112 |
| 2009 | — | Q4 | — | 1,6 | 1,6 | — | — | — |
| 2008 | — | Q4 | — | 1,5 | 1,5 | — | — | — |
| 2007 | — | Q4 | — | 1,5 | 1,4 | — | — | — |
| 2006 | — | Q4 | — | 1,5 | — | — | — | — |
| 2005 | — | Q4 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 1,4 | — | — | — | — |
| 2003 | — | Q3 | — | 1,5 | — | — | — | — |
| 2002 | — | Q3 | — | 1,6 | — | — | — | — |
| 2001 | — | Q3 | — | 1,3 | — | — | — | — |
| 2000 | — | Q3 | — | 1,6 | — | — | — | — |
| 1999 | — | Q3 | — | 1,4 | — | — | — | — |
| 1998 | — | Q2 | — | 1,1 | — | — | — | — |
| 1997 | — | Q1 | — | 1,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q2 | 56/207 |
| 2025 | IMMUNOLOGY | SCIE | Q1 | Q2 | 36/183 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q2 | 56/204 |
| 2024 | IMMUNOLOGY | SCIE | Q1 | Q2 | 38/183 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q2 | 69/205 |
| 2023 | IMMUNOLOGY | SCIE | Q2 | Q2 | 52/181 |
| 2022 | CELL BIOLOGY | SCIE | Q2 | Q2 | 52/191 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q2 | 42/161 |
| 2021 | CELL BIOLOGY | SCIE | Q2 | Q2 | 59/195 |
| 2021 | IMMUNOLOGY | SCIE | Q2 | Q2 | 46/162 |
| 2020 | CELL BIOLOGY | SCIE | Q2 | Q3 | 96/195 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q3 | 70/162 |
| 2019 | CELL BIOLOGY | SCIE | Q3 | Q3 | 116/195 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 90/159 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q3 | 114/193 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q3 | 87/158 |
| 2017 | CELL BIOLOGY | SCIE | Q3 | Q3 | 111/190 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q3 | 83/155 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 117/190 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 93/151 |
| 2015 | CELL BIOLOGY | SCIE | Q3 | — | 119/187 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 86/151 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 129/184 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 96/148 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 136/185 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 102/144 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 135/185 |
| 2012 | IMMUNOLOGY | SCIE | Q4 | — | 105/137 |
| 2011 | CELL BIOLOGY | SCIE | Q3 | — | 128/181 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 101/139 |
| 2010 | CELL BIOLOGY | SCIE | Q3 | — | 132/178 |
| 2010 | IMMUNOLOGY | SCIE | Q3 | — | 99/134 |
| 2009 | CELL BIOLOGY | SCIE | Q4 | — | 134/162 |
| 2009 | IMMUNOLOGY | SCIE | Q4 | — | 106/128 |
| 2008 | CELL BIOLOGY | SCIE | Q4 | — | 135/157 |
| 2008 | IMMUNOLOGY | SCIE | Q4 | — | 100/121 |
| 2007 | CELL BIOLOGY | SCIE | Q4 | — | 128/156 |
| 2007 | IMMUNOLOGY | SCIE | Q4 | — | 97/119 |
| 2006 | CELL BIOLOGY | SCIE | Q4 | — | 122/156 |
| 2006 | IMMUNOLOGY | SCIE | Q4 | — | 94/117 |
| 2005 | CELL BIOLOGY | SCIE | Q4 | — | 123/153 |
| 2005 | IMMUNOLOGY | SCIE | Q4 | — | 94/115 |
| 2004 | CELL BIOLOGY | SCIE | Q3 | — | 114/155 |
| 2004 | IMMUNOLOGY | SCIE | Q4 | — | 84/111 |
| 2003 | CELL BIOLOGY | SCIE | Q3 | — | 108/156 |
| 2003 | IMMUNOLOGY | SCIE | Q3 | — | 77/114 |
| 2002 | CELL BIOLOGY | SCIE | Q3 | — | 97/153 |
| 2002 | IMMUNOLOGY | SCIE | Q3 | — | 76/119 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 200/308 |
| 2001 | CELL BIOLOGY | SCIE | Q3 | — | 101/147 |
| 2001 | IMMUNOLOGY | SCIE | Q3 | — | 77/114 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 183/310 |
| 2000 | CELL BIOLOGY | SCIE | Q3 | — | 92/147 |
| 2000 | IMMUNOLOGY | SCIE | Q3 | — | 72/116 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 172/295 |
| 1999 | CELL BIOLOGY | SCIE | Q3 | — | 88/141 |
| 1999 | IMMUNOLOGY | SCIE | Q3 | — | 72/115 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 187/295 |
| 1998 | CELL BIOLOGY | SCIE | Q3 | — | 99/139 |
| 1998 | CHEMISTRY | SCIE | Q2 | — | 34/126 |
| 1998 | IMMUNOLOGY | SCIE | Q3 | — | 79/120 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 86/178 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 123/253 |
| 1997 | CELL BIOLOGY | SCIE | Q2 | — | 62/130 |
| 1997 | CHEMISTRY | SCIE | Q1 | — | 23/111 |
| 1997 | IMMUNOLOGY | SCIE | Q2 | — | 55/117 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 45/157 |